Hong Kong Life Sciences and Technologies Lim : notice of board meeting

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Hong Kong Life Sciences and Technologies Group Limited 香港生命科學技術集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 8085)

NOTICE OF BOARD MEETING

The board (the "Board") of directors (the "Directors") of Hong Kong Life Sciences and Technologies Group Limited (the "Company") hereby announces that a meeting of the Board will be held at Unit 2704, 27/F, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong on Monday, 12 February 2018 to transact the following businesses:

• 1. to consider and approve the unaudited consolidated results of the Company and its subsidiaries for the nine months ended 31 December 2017 (the "Third Quarterly Results") and to approve the drafts announcement and report of the Third Quarterly Results to be published on the websites of the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited ("GEM") and the Company;

• 2. to consider the payment of an interim dividend, if any;

• 3. to consider the closure of the register of members of the Company, if necessary; and

• 4. to transact other business, if any.

By order of the Board

Hong Kong Life Sciences and Technologies Group Limited

Lu Zhiqiang

Executive Director and Chief Executive Officer

Hong Kong, 31 January 2018

As at the date of this announcement, the Board comprises (i) five executive Directors, namely, Mr. David Lin Kao Kun, Mr. Lu Zhiqiang, Mr. Chui Kwong Kau, Ms. Li Mei and Dr. Sun Yu; (ii) one non-executive Director, namely Ms. Lam Kuo; and (iii) four independent non-executive Directors, namely Mr. Hung Yat Ming, Mr. Chan Yun Hing, Mr. Gui Qiangfang and Mr. Zhang James Jian Yuan.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on GEM for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.

This announcement will remain on the "Latest Company Announcements" page of the GEM website athttp://www.hkgem.comfor a minimum period of seven days from the date of its publication and on the Company's website athttp://www.hklifesciences.com.